Biol Reprod
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xing, W.
Right arrow Articles by Ram Sairam, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xing, W.
Right arrow Articles by Ram Sairam, M.
Agricola
Right arrow Articles by Xing, W.
Right arrow Articles by Ram Sairam, M.
Biology of Reproduction 64, 579-589 (2001)
© 2001 Society for the Study of Reproduction, Inc.


Regular Article

Characterization of Regulatory Elements of Ovine Follicle-Stimulating Hormone (FSH) Receptor Gene: The Role of E-Box in the Regulation of Ovine FSH Receptor Expression1

Weirong Xinga,b, and M. Ram Sairam2,a,b,c

a Molecular Reproduction Research Laboratory, Clinical Research Institute of Montreal, Montreal, Quebec, Canada H2W 1R7 b Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, Quebec, Canada H3A 1A3 c Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada H3T 1J4

ABSTRACT

Expression and activation of follicle-stimulating hormone receptor (FSHR) in the granulosa and Sertoli cells are required for normal development of the ovarian follicles and germ cells. However, little is known regarding the mechanisms by which FSHR expression is regulated. We fused an ovine FSHR promoter to a luciferase gene to understand the promoter regulation in two gonadal cell lines. Deletion studies revealed that the strongest promoter was at -200 to +163 relative to the transcription start site. One of cis-elements protected from DNase I digestion was mapped to between +32 and +54 of the 174-base pair (bp) minimal promoter. Electrophoretic mobility shift assay with a 26-bp probe (+32 to +57) and nuclear extracts from Sertoli (15P1) and granulosa (JC-410) cell lines demonstrated a sequence-specific DNA-protein complex. Southwestern analysis detected a 43-kDa protein bound to the 26-bp probe. Gel supershift with upstream stimulatory factor 1 and 2 (USF-1/2) antibodies revealed that the DNA-protein complex contained these two transcription factors. Mutation within the E-box of the promoter abolished the sequence-specific binding and the minimal promoter activity but also greatly reduced the transcription of the proximal promoters by 49%–70%. These data suggest that the USF-1/2 binding to the promoter is required for the expression of the ovine FSHR in the gonadal cells.

FSH receptor, gene regulation, granulosa cells, Sertoli cells

INTRODUCTION

Follicle-stimulating hormone (FSH) released from the pituitary plays an important role in mammalian reproduction by interacting with its specific receptor in target cells of the ovary and testis [1, 2]. On FSH binding, the FSH receptor (FSHR) was initially thought to couple exclusively with the Gs protein, stimulating the enzyme adenylyl cyclase or other pathways to initiate a cascade of intracellular events leading to the specific biological effects of the gonadotropin [1]. This simplified view now appears to be more complex following the cloning of several alternatively spliced transcripts from the sheep testis [3, 4] and the functional studies of the corresponding proteins [5, 6]. Some of the alternatively spliced transcripts coding for proteins with a novel structural motif of the growth factor type I receptor mediate FSH action through the activation of calcium signaling pathways distinct from the Gs-coupled receptor [5]. Our recent homologous recombination study describing the knockout of the FSHR gene, eliminating all forms of the receptor, has confirmed their critical role in gonadal development and function [7].

Expression of the FSHR appears to undergo a cyclic change, indicating possible transcriptional regulation by hormones and growth factors by mechanisms that are not yet fully defined [810]. The promoter regions of the FSHR have been cloned from a number of species, including human, rat, mouse, and sheep [1114]. By RNase protection or primer extension analysis, a major transcription start site has been localized at -99 in the human and -534 in the mouse relative to the translation start site [11, 14]. In the rat, two major transcription start sites, at positions -80 and -98, have been found [12]. In these three species, additional minor transcription initiation sites have also been observed [11, 12, 14]. However, a unique transcription start site in the ovine FSHR has been mapped at -163 relative to the translation initiation codon [13]. Sequence comparison of the putative promoter regions in these four species has revealed some diversity in the regions upstream of the transcription start site relative to the ovine gene [1114]. The 5'-flanking regions of the FSHR from the human, rat, and sheep lack typical TATA or CCAAT boxes [1113], whereas a TATA sequence element is present at 10 nucleotides upstream of the major transcription initiation site of the mouse FSHR promoter [14]. These promoters are of particular interest, because they could contain cell-specific regulatory elements that may be used to direct expression of transgenes with which to target the tissues for gene therapies. However, the precise mechanisms by which the FSHR promoter is regulated are not well known, largely because of a lack of extensive studies in different species.

We have cloned an 8-kilobase (kb) genomic EcoRI DNA fragment containing ovine FSHR 5'-flanking region and the first exon from a sheep genomic library [13]. Previous studies have demonstrated that this promoter contains several interesting regulatory elements, including those that may be specific for the germ cells [13]. In the present study, we have used the ovine FSHR gene and two gonadal cell lines as a model system to investigate the regulatory elements of the promoter. An involvement of two ubiquitous transcription factors, upstream stimulatory factors 1 and 2 (USF-1/2), in mediating promoter activity of the ovine FSHR in the gonadal cell lines was studied by progressive deletions and biochemical assays.

MATERIALS AND METHODS

Construction of Promoter/Luciferase Plasmids

Promoterless plasmid pGL3-basic (Promega, Madison, WI) was used for the preparation of the luciferase fusion reporter constructs. Various truncated ovine FSHR promoters were generated by polymerase chain reaction (PCR) from an 8-kb genomic EcoRI DNA fragment cloned from a sheep genomic library [13]. Seven promoter fragments were amplified, and the sequences of each pair of primers used for PCR are shown in Table 1. All the forward primers were designed with a sequence (5'-CGTAAGATCT) for a BglII site at their 5' ends, whereas the reverse primer was synthesized with a linker (5'-GCATAAGCTT) providing a HindIII site at their 3' ends. The PCR products were digested with BglII and HindIII and then inserted into the pGL3-basic vector at their corresponding sites in front of the luciferase gene. The DNA sequence of each of the promoter fragments was confirmed by sequencing before transfection.


View this table:
[in this window]
[in a new window]
 
TABLE 1. PCR primers used in generating ovine FSHR promoter fragments

Site-Directed Mutagenesis

Mutagenesis was performed using the QuikChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA). In brief, a double-stranded plasmid DNA with a wild-type FSHR promoter was used as a template. A pair of synthetic oligonucleotides with a directed mutation was extended by means of Pfuturbo DNA polymerase (Stratagene). The extension product was treated with 10 U of DpnI endonuclease at 37°C for 1 h to digest the parental double-stranded DNA template. The nicked-vector DNA incorporating a mutation was then transformed into Escherichia coli XL1-Blue Supercompetent Cells (Stratagene). Individual clones were isolated, and the DNA was then purified and sequenced to confirm which clones had the correct mutational changes.

DNA Sequence Analysis

The DNA sequence analysis was performed according to the manufacturer's instructions (Amersham Pharmacia Biotech, Piscataway, NJ) using the dideoxy chain-termination method with {alpha}-32P-deoxycytidine triphosphate. The reaction products were resolved on a 7% polyacrylamide denaturing gel. The gel was dried before autoradiography at room temperature with Kodak X-OMAT AR 5 film (Rochester, NY).

Cell Lines and Cell Culture

A mouse Sertoli cell line (15P1) established from testicular cells of adult transgenic mice that express the large T antigen of polyoma virus was kindly provided by Dr. Francois Cuzin (University of Nice, Nice Cedex 2, France) [15]. A stable and spontaneously immortalized porcine ovarian granulosa cell line (JC-410) was a generous gift from Dr. Jorge P. Chedrese (University of Saskatchewan, Saskatoon, Canada) [16]. These cell lines do not appear to express endogenous FSHR, because they fail to respond to FSH stimulation [15, 16]. The cells were routinely maintained in a humidified, 37°C (JC-410) or 32°C (15P1) incubator with 5% CO2 and cultured in F-12/Dulbecco's modified Eagle's medium (DMEM; Gibco BRL, Gaithersburg, MD) containing 10% fetal bovine serum, 2 mM L-glutamine, 100 U/ml of penicillin, and 100 µg/ml of streptomycin.

Transfections and Luciferase Assay

The 15P1 or JC-410 cells were seeded into 60-mm tissue culture plates (5 x 105 cells/plate) in F12/DMEM medium plus 10% fetal bovine serum. Transient transfections were carried out with 8 µg of FSHR promoter/luciferase reporter and 1 µg of a pCMVlacZ for 18 h using calcium phosphate coprecipitation [17]. The following day, fresh medium was added for an additional 48 h before harvesting. Appropriate aliquots of cell extract were used for both luciferase and ß-galactosidase assays, which were performed as recommended by the manufacturer (Tropix, Bedford, MA). To normalize the transfection efficiency, the light units from the luciferase constructs were divided by the light readings from the ß-galactosidase internal controls.

Preparation of Nuclear Extract

Nuclear extracts were prepared as described previously [18]. Both 15P1 and JC-410 cells were lysed on ice for 5 min in buffer E (0.3% NP-40, 10 mM Tris-HCl [pH 8.0], 60 mM NaCl, 1 mM EDTA, 1 mM 1,4-dithiothreitol [DTT], and 1 mM phenylmethylsulfonylfluoride [PMSF]). Nuclei were pelleted by spinning for 5 min at 2500 rpm at 4°C. The pellet was washed in buffer E lacking NP-40 and resuspended in buffer C (20 mM Hepes [pH 7.9], 0.75 mM spermidine, 0.15 mM spermine, 0.2 mM EDTA, 2 mM EGTA, 2 mM DTT, 20% glycerol, and 1 mM PMSF). Next, NaCl was added to a final concentration of 0.4 M, and the nuclei were gently shaken for 20 min at 4°C, then spun for 10 min at 12 000 rpm at 4°C. Nuclear extracts were stored at -80°C.

Electrophoretic Mobility Shift Assay

The oligonucleotides footprinting 1 (FP1) and mutated FP1 (FP1mt) were synthesized by a local supplier:

FP1: 5'-GGGCGGGTCACGTGACCCTACCAGCT

3'-CCCGCCCAGTGCACTGGGATGGTCGA

[rpFP1mt:[sp[fy21,1] 5'-GGGCGGGTCaaTTGACCCTACCAGCT

3'-CCCGCCCAGttAACTGGGATGGTCGA

The electrophoretic mobility shift assays (EMSAs) were performed as described previously [17]. Briefly, double-stranded oligonucleotides were labeled at the 5' ends using T4 polynucleotide kinase and {gamma}-32P-ATP. Nuclear extracts (5 µg) from 15P1 and JC-410 cells or purified recombinant USF-1 protein (10 ng; a gift of Drs. D. Steger and J. Workman, Pennsylvania State University, University Park, PA) [17, 19] were incubated in a binding buffer containing 10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 3 mM DTT, 10% glycerol, 0.05% NP-40, 0.1 mM ZnCl2, 50 µg/ml poly(dI-dC), and 20 fmol of labeled DNA probe. After addition of the radiolabeled probe, the mixture was incubated at room temperature for another 15 min. Excess unlabeled DNA competitors were added 5 min before adding the radiolabeled DNA probe. The reaction mixture was analyzed using a 5% nondenaturing polyacrylamide gel in 1x TBE buffer (50 mM Tris-borate-EDTA, pH 8.0). For the gel supershift assay, 1 µg of USF antibody or preimmune control immunoglobulin (Ig) G (Santa Cruz Biotechnology, Santa Cruz, CA) was added to the reaction mixture and incubated at room temperature for an additional 15 min. Gels were then dried and visualized by autoradiography.

Southwestern Analysis

The Southwestern analyses were performed as described previously [20]. Briefly, 120 µg of nuclear extracts were loaded on to a SDS-PAGE denaturing gel, and electrophoresis was carried out at 15 mA for 5 h. Proteins were then transferred to a nitrocellulose membrane and incubated at room temperature for 60 min in a buffer containing 5% dry skim milk, 25 mM NaCl, 5 mM MgCl2, 25 mM Hepes (pH 7.9), and 0.5 mM DTT. The binding reaction was performed in the same buffer with 106 cpm/ml of 32P-labeled, double-stranded DNA probe in the presence of 5 µg/ml of salmon sperm DNA at room temperature for 18 h. Before autoradiography, blots were washed four times at room temperature utilizing the same buffer.

DNase I Footprinting

Coding strand probes were prepared by linearizing proper plasmids (P174, p363, and P363mt) with HindIII. Noncoding strand probes were prepared by cutting the same plasmids with BglII and 32P-5' end labeled with T4 polynucleotide kinase. Labeled DNA was run through a ProbeQuant G-50 column (Amersham Pharmacia Biotech) to remove free nucleotides. The coding and noncoding probes were released from the plasmids by digesting with BglII and HindIII, respectively, and were purified by 1% agarose gel electrophoresis. The DNase I footprinting reactions were carried out as described previously [21]. Binding reactions containing 25 mM HEPES (pH 7.6), 5 mM MgCl2, 84 mM KCl, 5% glycerol, 1 mM DTT, 1 µg of poly(dI-dC), 20 µg of nuclear extract or 40 ng of purified USF-1, and 1 µl of labeled template DNA (~20 000 cpm) were incubated at temperature for 15 min, followed by 5 min of DNase I digestion on ice. The footprint reactions were terminated by the addition of 80 µl of a stop buffer (20 mM Tris-HCl [pH 8.0], 250 mM NaCl, 20 mM EDTA, 0.5% SDS, 50 µg/ml of salmon sperm DNA, and 250 µg/ml of proteinase K). The samples were incubated at 45°C for 1 h and then extracted twice with phenol/chloroform. Finally, after ethanol precipitation, the samples were loaded on a 7% sequencing gel along with A, C, G, and T DNA sequence tracks, followed by autoradiography.

RESULTS

Deletion Analysis of the Ovine FSHR Promoters

To map regulatory elements and to analyze the truncated promoter function, portions of the ovine FSHR promoter were amplified and cloned into the promoterless pGL3-basic vector (Fig. 1). Promoter activity was analyzed in transiently transfected 15P1 and JC-410 cells (Fig. 1). All constructs were able to transcribe a luciferase reporter gene in JC-410 cells, whereas five of seven (i.e., P1268, P807, P468, P363, and P174) were active in 15P1 cells. Generally, the luciferase activity of the same construct was 1.6-to 14.0-fold higher in JC-410 cells than in 15P1 cells (Fig. 1). The longest construct P1268, containing nucleotides from -1105 to +163 relative to the transcription start site, showed 25-fold higher activity in JC-410 cells and 7-fold higher activity in 15P1 cells compared to the pGL3-basic vector (Fig. 1). Deletion from -1105 to -644 (P807) resulted in a reduction of promoter activity by 24% in JC-410 cells but an increase by 70% in 15P1 cells (Fig. 1). Further deletion of 286 base pairs (bp) from the 5'-flanking end (P519) did not alter the level of expression in JC-410 cells but reduced its expression to near basal level of the promoterless vector in 15P1 cells (Fig. 1). Further stepwise deletions from -356 to -305, or -200, greatly increased in the luciferase activity in both cell lines, suggesting the possible presence of inhibitory sequences in these two regions (Fig. 1). The construct of P363 containing the fragment from -200 to +163 conferred the strongest promoter activities, which were 138-fold higher in JC-410 cells and 42-fold higher in 15P1 cells than in pGL3-basic vector level (Fig. 1). Additional removal of 94 bp from the 5' end of P363 (P269) reduced the luciferase expression by 84% in JC-410 cells and by 96% in 15P1 cells, suggesting the possible presence of strong enhancer(s) in this region. Interestingly, a construct only containing nucleotides from -11 to +163 (P174) led to 32-fold higher activity in JC-410 cells and fivefold higher activity in 15P1 cells than in the pGL3-basic vector (Fig. 1).



View larger version (27K):
[in this window]
[in a new window]
 
FIG. 1. Deletion analysis of the ovine FSHR gene promoter. A series of truncated fragments of the promoter region were fused in front of the luciferase gene in the promoterless vector pGL3-basic. The fusion constructs and the pGL3-basic were transiently cotransfected with pCMVLacZ in JC-410 and 15P1 cells. The relative luciferase activity was normalized to ß-galactosidase activity and expressed as fold induction over the activity of the pGL3-basic. Data are shown as mean ± SD from three independent experiments. Statistical significance (P < 0.05 compared to promoterless vector control by Student's t-test) is indicated by an asterisk

Identification of the Regulatory Element and Its Binding Protein

Promoter deletion analysis has localized several positive and negative regulatory regions (Fig. 1). To map the cis-elements within the ovine FSHR promoter, we performed a DNase I footprinting assay using P519, P363, and P174 plasmid as templates (Fig. 1). At least five cis-elements within a 519-bp length of FSHR promoter are recognized by the nuclear proteins and are protected from DNase I digestion (Fig. 2). The FP1 was mapped from nucleotides +32 to +54 of the 174-bp minimal promoter (Fig. 2, A and B). It may be noted that sites which are hypersensitive to DNase I digestion can also be seen above the footprinting regions.



View larger version (64K):
[in this window]
[in a new window]
 
FIG. 2. In vitro DNase I footprinting with nuclear extract from JC-410 or 15P1 cells. The 174-bp (P174) DNA fragment shown in Figure 1 was 5'-end labeled either on the coding strand (A) or the noncoding strand (B). The DNA templates were then subjected to the DNase I digestion in the presence or absence of nuclear extract from the indicated cell lines as described in Materials and Methods. The digested DNA was analyzed on a 7% polyacrylamide denaturing gel, followed by autoradiography. Brackets indicate the regions of protection from DNase I digestion, and arrowheads indicate DNase I hypersensitive sites. A portion of the FSHR promoter sequence (+25 to +64) relative to the transcription start site is given at the bottom of the panel. The protected sequence against DNase I digestion in the presence of the nuclear extracts is indicated by bars facing the corresponding strand. Hypersensitive sites induced by nuclear proteins are indicated with arrows. Lanes 1–4: DNA sequence tracks; lane 5: DNase I digestion without nuclear extract (-NE); lanes 6 and 7: DNase I digestion with 20 µg of nuclear extracts (+NE)

To identify transcription factors that bind to the FP1 region, we synthesized oligonucleotides that encompass sequences from +32 to +57 of the ovine FSHR promoter (see Materials and Methods). The FP1 sequence overlapped a GC (GGGCGGG) box, a half-hormone response element (5'-TGACC), and a consensus E-box (5'-GGTCACGTGACC) as potential transcription factor-binding sites. Using this double-stranded DNA probe, our EMSAs detected a single retarded protein-DNA complex with the nuclear extracts from both 15P1 and JC-410 cells (Fig. 3). This binding appeared to be sequence specific, because it was competed by the unlabeled FP1 probes in a concentration-dependent manner, but not by an unrelated DNA sequence, Sp-1, Egr-1, and consensus estrogen-responsive elements (Fig. 3).



View larger version (75K):
[in this window]
[in a new window]
 
FIG. 3. Sequence-specific protein binding to FP1 double-stranded oligonucleotides. The EMSA was conducted using nuclear extracts (5 µg) from JC-410 and 15P1 cells with a 32P-labeled FP1 probe. The binding reactions were analyzed on a 5% polyacrylamide nondenaturing gel, followed by autoradiography. Lanes 1 and 6: probe control without nuclear extracts; lanes 2 and 7: probe with nuclear extract from JC-410 and 15P1 cells, respectively; lanes 3 and 4: probe with nuclear extract from JC-410 cells, the reaction containing 50- and 200-fold molar excess of unlabeled double-stranded FP1 oligonucleotides, respectively; lanes 5 and 9: probe with nuclear extract from JC-410 and 15P1 cells, respectively, the reaction containing 200-fold molar excess of unlabeled, nonspecific double-stranded oligonucleotides; lane 8: probe with nuclear extract from 15P1 cells, the reaction containing 200-fold molar excess of unlabeled double-stranded FP1 oligonucleotides. The sequences of the oligonucleotides used are given below the panel

To characterize the nuclear protein(s) that bind the FP1 probe, we performed a Southwestern blot analysis. The FP1 probe specifically recognized a protein with an apparent molecular weight of 43 kDa in nuclear extracts from both 15P1 and JC-410 cells (Fig. 4). To test whether USF-1 and USF-2, whose molecular weights are approximately 43 and 44 kDa, respectively, among E-box-binding proteins bind to that region, we turned to antibody supershift assay with anti-USF-1 and anti-USF-2 antibodies. The DNA-nuclear protein complexes were supershifted in the presence of either USF-1 or USF-2 antibodies but were unaffected by control rabbit IgG (Fig. 5). This would be consistent with a USF-1/2 heterodimer at the promoter, because both antibodies shifted the same DNA-protein complex. Further experiments confirmed that the interactions include USF-1 and USF-2 by demonstrating that the retarded band with purified USF-1 displayed a migration similar to that of the DNA-protein complex as in 15P1 and JC-410 nuclear extracts (Fig. 5). Moreover, USF-1-DNA complex was supershifted by USF-1 antibody in the same way as the DNA complex with the nuclear proteins from 15P1 and JC-410 cells (Fig. 5).



View larger version (45K):
[in this window]
[in a new window]
 
FIG. 4. Southwestern analysis of FP1 DNA-binding proteins. An aliquot (120 µg) of nuclear extracts from 15P1 and JC-410 cells were separated on 10% SDS-PAGE. The proteins were transferred to a nitrocellulose membrane and probed with 32P-labeled FP DNA probe, followed by autoradiography. Lane 1: nuclear extract from 15P1 cells; lane 2: nuclear extract from JC-410 cells



View larger version (66K):
[in this window]
[in a new window]
 
FIG. 5. Binding of USF to the FP1 sequence as a heterodimer in nuclear extracts. Nuclear extract from JC-410 and 15P1 cells or purified recombinant USF-1 was used for a gel supershift assay using the same procedures as in Figure 3, except that incubation was extended by 15 min after addition of antibodies or control IgG (1 µg). Lanes 1 and 6: probe with antibody but without nuclear extract; lanes 2 and 7: probe with nuclear extract from JC-410 and 15P1 cells, respectively; lanes 3 and 8: probe with nuclear extract from JC-410 and 15P1 cells, respectively, the reaction containing polyclonal USF-1 antibody; lanes 4 and 9: probe with nuclear extract from JC-410 and 15P1 cells, respectively, the reaction containing polyclonal USF-2 antibody; lanes 5 and 10: probe with nuclear extract from JC-410 and 15P1 cells, respectively, the reaction containing rabbit IgG; lane 11: probe with purified recombinant USF-1; lane 12: probe with purified recombinant USF-1, the reaction containing polyclonal USF-1 antibody

The protein-DNA complex detected in EMSAs may contain one or more classes of proteins bound to the same region of promoter context, as predicted by computer-based sequence analysis. To rule out the participation of other transcription factors in the complex, we compared purified USF-1 protein with the nuclear extracts from 15P1 and JC-410 cells by DNase I footprinting assays (Fig. 6). This experiment is also more precise in mapping the protein-DNA binding with a single nucleotide resolution. The DNase I footprinting with a purified USF-1 protein demonstrated the same protected region within the FSHR promoter as in the nuclear extracts from either 15P1 cells or JC-410 cells (Fig. 6). These data are in agreement with the results of EMSA and supershift assays, suggesting that USF-1 and USF-2 are the predominant factors bound to the E-box region of the promoter.



View larger version (47K):
[in this window]
[in a new window]
 
FIG. 6. Binding of USF to the E-box of the ovine FSHR promoter. A 363-bp (P363) promoter fragment was used for the DNase I footprinting as in Figure 2 using a purified recombinant USF-1 protein (40 ng) or nuclear extracts (20 µg) from 15P1 and JC-410 cells. A bracket indicates the protection region of coding strand from DNase I digestion, and an arrowhead indicates the DNase I hypersensitive site. Lanes 1–4: DNA sequence tracks; lane 5: mock DNA treated with DNase I in the presence of BSA; lanes 6 and 7: DNA treated with DNase I in the presence of nuclear extracts from 15P1 and JC-410 cells, respectively; lane 8: DNA treated with DNase I in the presence of purified recombinant USF-1

E-Box Mutation Reduces USF Binding and Promoter Activities

Previous studies have shown that in the E-box enhancer sequence, the central nucleotides of CG are the most important for USF binding [17]. To understand the contributions of the E-box to the promoter activity of the ovine FSHR, we mutated the central CG to AT (leaving the E-box consensus sequence, CAatTG) and used the FP1mt to test the USF binding. The EMSA showed that the FP1mt probe was not bound by the nuclear proteins from either 15P1 or JC-410 cells (Fig. 7). In addition, the mutated probe failed to compete for the binding to wild-type probe (FP1), even at 200-fold molar excess (Fig. 7). To further test whether the E-box mutation within the promoter region would completely abolish the protein binding, we incorporated the same mutations as the FP1 into a FSHR promoter/luciferase constructs. Our DNase I footprinting assay in vitro failed to detect any protein binding to the mutated E-box sequence, because the promoter template was digested in the presence of nuclear extracts or USF-1 protein (Fig. 8). In contrast, the nuclear extract from JC-410 cells as well as the purified USF-1 effectively bound to the corresponding region of the wild-type promoter, therefore protecting it from DNase I digestion (Fig. 8).



View larger version (69K):
[in this window]
[in a new window]
 
FIG. 7. E-box mutation abolishes USF binding to the FP1mt probe. An EMSA was performed as in Figure 3. A competition experiment was conducted by adding a 200-fold molar excess of unlabeled probe to the binding reaction. Lanes 1 and 6: FP1 probe with nuclear extract from JC-410 and 15P1 cells, respectively; lanes 2 and 7: FP1 probe with nuclear extract from JC-410 and 15P1 cells, respectively, the reaction containing a 200-fold molar excess of unlabeled FP1 oligonucleotides; lanes 3 and 8: FP1 probe with nuclear extract from JC-410 and 15P1 cells, respectively, the reaction containing a 200-fold molar excess of unlabeled FP1mt oligonucleotides; lane 4: labeled FP1mt probe alone; lanes 5 and 9: labeled FP1mt probe with nuclear extract from JC-410 and 15P1 cells, respectively. Sequences of the wild-type FP1 probe and the mutated FPmt probe are given at the bottom of the panel



View larger version (54K):
[in this window]
[in a new window]
 
FIG. 8. E-Box mutation abolishes nuclear protein binding to the promoter. The 363-bp (P363 or P363mt) coding strands were used for the DNase I footprinting as in Figure 2. Brackets indicate the regions of protection from DNase I digestion, and arrowheads indicate DNase I hypersensitive sites. Lanes 1–4: DNA sequence tracks with mutated template; lane 5: mutated template treated with DNase I in the absence of nuclear extract or USF-1; lanes 6 and 7: mutated template treated with DNase I in the presence of nuclear extract from JC-410 cells and of purified recombinant USF-1, respectively; lane 8: wild-type template treated with DNase I in the absence of nuclear extract and USF-1; lanes 9 and 10: wild-type template treated with DNase I in the presence of nuclear extract from JC-410 cells and of purified recombinant USF-1, respectively

To test the contribution of USF binding to the promoter's function, we made three constructs containing the same mutated E-box within a 807-, 363-, and 174-bp length of FSHR promoters (Fig. 1). We transiently transfected those reporter genes into 15P1 and JC-410 cells to analyze the luciferase activities (Fig. 9). In agreement with the USF-binding experiments shown in Figures 5 and 8, luciferase assays demonstrated that the E-box mutation completely abolished the promoter activities in P174mt transfected cells (Fig. 9A). Interestingly, the same mutation within the 363-bp length of promoter from -200 to +163 had a moderating effect in reducing the promoter activities by 49% in JC-410 cells and 63% in 15P1 cells (Fig. 9B). Similar results were found for the P807mt construct (Fig. 9C), in which luciferase expression was diminished by approximately 70% in both cell lines. Finally, whereas the expression of luciferase from the mutated promoters (P363mt and P807mt) was significantly less than that seen with the wild types, the mutated promoters still represented significant induction over the basal level of promoterless vector (Fig. 9, B and C). In contrast, the mutated minimal promoter (P174mt) was actually below the level of the vector control (Fig. 9A). These elevations of P363mt and P807mt constructs are attributable to the presence of regulatory elements upstream of the transcription start site. Because the identity of the upstream factors is still under investigation, it is not yet possible to provide data on the interaction between USF and other factors. However, the notable reduction in the promoter activity of the constructs P363mt and P807mt could highlight the importance of the USF-E-box interaction in the activation of ovine FSHR promoter.



View larger version (39K):
[in this window]
[in a new window]
 
FIG. 9. E-Box mutation reduces in the promoter activities. A luciferase assay was carried out as in Figure 1 using a series of reporter gene constructs with either wild-type promoter or the promoter with a mutated E-box. A) The JC-410 and 15P1 cells were transfected with a luciferase gene fused to a 174 bp of wild-type promoter (P174; see Fig. 1) or a similar promoter containing a mutant E-box (P174mt). B) The JC-410 and 15P1 cells were transfected with a luciferase gene fused to a 363 bp of wild-type promoter (P363; see Fig. 1) or a corresponding promoter containing a mutant E-box (P363mt). C) The JC-410 and 15P1 cells were transfected with a luciferase gene fused to 807 bp of wild-type promoter (P807; see Fig. 1) or a corresponding promoter containing a mutant E-box (P807mt). The relative luciferase activity was normalized and expressed as in Figure 1

DISCUSSION

In the male and female, selective FSHR expression in the gonads seems to be stage dependent, which coincides with the different maturational status of the germ cells or follicles [2224]. This expression pattern of the FSHR appears to be regulated by many paracrine/autocrine factors and gonadotropic hormones by either affecting mRNA stability or modulating the regulatory elements in the promoter region [2530]. Therefore, identification of the cis-elements within the 5'-flanking region of the FSHR gene is important, because this inducible, tissue-specific promoter could direct a transgene in the ovary and the testis. In our studies, we used the ovine FSHR promoter/luciferase gene as a model system to examine the promoter regulation because of the extensive information available regarding the promoter sequence and the interesting regulatory elements described previously [13]. We made a series of promoter deletions and assayed their activities in 15P1 and JC-410 cells (Fig. 1). Our transfection studies revealed that the promoter constructs were more active in JC-410 cells than in 15P1 cells after normalizing the transfection efficiency (Fig. 1). The expression profiles of the promoter constructs were generally similar in the two cell lines, except for P807, which gave rise to an opposite result after a deletion from -1105 to -644 (Fig. 1). However, deletion and transfection studies suggest that at least two positive (-200 to -107 and -11 to 163) and three negative regulatory regions (-356 to -306, -305 to -199, and -106 to -10) have been roughly localized within the 519-bp length of promoter (Fig. 1). Our analyses demonstrated that the minimal promoter is from -11 to +163 relative to the transcription start site, which confers 23% and 12% of the strongest promoter activity in JC-410 and 15P1 cells, respectively (Fig. 1, P174). The strongest promoter identified in the present study is located from -200 to +163, which should contain both negative and positive cis-elements (Fig. 1, P363). Further DNase I footprinting studies with the 174-bp minimal promoter revealed a positive regulatory element of 26-bp DNA from +32 to +54 (Fig. 2, A and B). Subsequent biochemical experiments with a probe and nuclear extracts demonstrated that the binding proteins correspond to two transcription factors, USF-1 and USF-2 (Figs. 3–6). A site-directed mutation within the E-box of the promoter prevented the sequence-specific binding as detected by gel shift and DNase I footprinting assays (Figs. 7 and 8). Incorporation of the same mutant E-box into the wild-type promoter/luciferase reporters completely blocked the minimal promoter activity (Fig. 9A) but greatly diminished the transcriptions of the proximal promoters by 49%–70% (Fig. 9, B and C). These experiments suggest that one of the regulatory elements, an E-box downstream of the transcription start site, is required for the FSHR expression.

Direct studies of the ovine FSHR promoter regulation in a homologous system would be ideal but, currently, are difficult, requiring the use of primary cultures from the ovary and testis. The alternative of using immortalized granulosa or Sertoli cell lines from the same species is also precluded, because these are not yet available. However, that the rat FSHR promoter was tissue-specifically active in a transgenic mouse [8] and the human FSHR promoter displayed its activities in the same way in the rat Sertoli cell line as in primary human granulosa cells [11] suggests that target cells from heterologous species can be used for dissecting the promoter. Moreover, rat FSHR promoter was equally active in a mouse Sertoli cell line (MSC-1) and primary rat Sertoli cells [31, 32]. These studies indicate that the transcription factors that are important for the FSHR expression are well conserved among the mammalian species. Based on these considerations, we utilized the 15P1 and JC-410 cell lines that have been recently established and characterized [15, 16] as a first step and model system to localize the regulatory elements for the ovine FSHR promoter and to identify the potential binding proteins. These two cell lines exhibit many features that are characteristic of granulosa and Sertoli cells [15, 16, 33, 34], including transcription of a detectable mRNA [35], suggesting that the endogenous promoters, though very weak, are nevertheless active. By transfecting the nonchromatin promoters into these cells, avoiding repression by the chromatin structure and DNA methylation, we have demonstrated here that ovine FSHR promoters are active in both cell lines. The great difference of luciferase activity from the same construct in the two cell lines (Fig. 1) could be cell-line dependent, because they were derived from different sexes as well as from different species. The 15P1 cells came from the testis of the adult male mouse, whereas the JC-410 cells were derived from the pig ovary. Therefore, further studies need to be carried out in primary cell culture from sheep. Notwithstanding these caveats, our experiments suggest that the JC-410 cell line would be a better in vitro granulosa cell model for the transcriptional studies of FSHR gene and, perhaps, of other genes as well.

The consensus E-box in the FSHR promoter is located 110 bp upstream of the translation start site [13]. In fact, the similar sequence of an E-box overlapped with a GC box and a half-estrogen responsive element is conserved in the comparable regions of the mouse, rat, and human FSHR promoters [13]. This suggests that transcription factors binding to this region play an important role in FSHR gene expression. Our experiments have demonstrated that major E-box-binding components contain USF-1/2 transcription factors rather than other transcription factors, such as Myo D, c-myc, and USF-like binding proteins, that are predicted to recognize this sequence [31, 32, 3639]. In fact, the portion of promoter from -15 to +163 of the ovine FSHR gene is highly homologous to those of the other species, and some regions were thought to be important for rat FSHR transcription [13, 32]. However, our in vitro DNase I footprinting assays detected a unique protein-DNA interaction within the 174 bp of the minimal promoter (Figs 2, 6, and 8). This technique enabled us to identify the proteins that actually interact with a promoter from potential binding sites predicted through computer-based analysis or simple deletion studies [11, 13, 14, 32]. Indeed, our experiments suggest that the presence of a number of potential regulatory elements does not necessarily mean that their proteins potentially bind to them. Therefore, the sequence adjacent to the E-box may function through positioning an E-box at a proper space in the architecture of promoters and determine which factor activates via this site, because block replacements of the flanking sequences significantly affected the USF function in the rat FSHR model system [32].

The mechanisms of tissue-specific gene expression include the interaction of regulatory factors, DNA methylation, chromatin structure and remodeling, modification of chromatin assembly proteins, and mRNA or protein turnover. Previous studies have shown that a 5-kb rat FSHR promoter could direct a tissue-specific expression of a reporter gene in vivo [8]. However, a series of constructs containing a portion of promoter from 280 bp to 5 kb fused to a reporter gene failed to demonstrate Sertoli cell-specific expression in transiently transfected cell lines [32]. Moreover, human FSHR promoter is active in the Chinese hamster ovary cell line, and rat promoter activity could be detected in the Leydig cell line [8, 11, 32]. Recent studies have shown that methylation within the regulatory region of the promoters represses the endogenous gene expression in nongonadal cells of the transgenic mice and the mouse Sertoli cell line (MSC-1) [8]. These studies suggest that chromatin architecture and DNA methylation might play an important role in the cell-specific regulation of FSHR in vivo and the gene silencing in vitro. Previous studies have demonstrated that USFs not only participate in remodeling chromatin to allow tissue-specific transcription factors to establish a preinitiation complex but also are directly involved in recruitment of the general transcription machinery to the promoter [31, 4044]. Therefore, studies on the interactions of USFs with their upstream regulators on the chromatin template of the ovine FSHR and their contributions to the cell-specific expression as well as initiation would be of interest for future investigations.

ACKNOWLEDGMENTS

We are grateful to Drs. P.J. Chedrese (University of Sasketchwan, Saskatoon, Canada) and F. Cuzin (University of Nice, Nice, France) for providing the cell lines used in this study. The secretarial assistance of Odile Royer is greatly appreciated.

FOOTNOTES

First decision: 11 July 2000.

1 Supported by grants from the Canadian Institutes of Health Research (CIHR). W.X. is the holder of a doctoral scholarship award from the CIHR. Back

2 Correspondence: M. Ram Sairam, Molecular Reproduction Research Laboratory, Clinical Research Institute of Montreal, 110 Pine Avenue West, Montreal, Quebec, Canada H2W 1R7. FAX: 514 987 5585; sairamm{at}ircm.qc.ca Back

Accepted: September 11, 2000.

Received: June 5, 2000.

REFERENCES

  1. Sprengel R, Braun T, Nikolics K, Segaloff DL, Seeburg PH. The testicular receptor for follicle stimulating hormone: structure and functional expression of cloned cDNA. Mol Endocrinol 1990; 4:525–530.[Abstract]
  2. Simoni M, Gromoll J, Nieschlag E. The follicle stimulating hormone receptor. Biochemistry, molecular biology, physiology and pathophysiology. Endocr Rev 1997; 18:739–773.[Abstract/Free Full Text]
  3. Khan H, Yarney TA, Sairam MR. Cloning of alternative spliced mRNA transcripts coding for variants of ovine testicular follitropin receptor lacking the G protein coupling domains. Biochem Biophys Res Commun 1993; 190:888–894.[CrossRef][Medline]
  4. Yarney TA, Jiang LG, Khan H, MacDonald EA, Laird DW, Sairam MR. Identification of an isoform of the ovine testicular FSH receptor bearing a variant carboxyl terminus: structure and functional expression. Mol Reprod Dev 1997; 48:458–470.[CrossRef][Medline]
  5. Touyz RM, Jiang L, Sairam MR. Follicle-stimulating hormone mediated calcium signaling by the alternatively spliced growth factor type I receptor. Biol Reprod 2000; 62:1067–1074.[Abstract/Free Full Text]
  6. Sairam MR, Jiang LG, Yarney TA, Khan H. Alternative splicing converts the G-protein coupled follitropin receptor gene into a growth factor type I receptor: implications for pleiotropic actions of the hormone. Mol Reprod Dev 1997; 48:471–479.[CrossRef][Medline]
  7. Dierich A, Sairam MR, Monaco L, Fimia GM, Gansmuller A, LeMeur M, Sassone-Corsi P. Impairing follicle-stimulating hormone (FSH) signaling in vivo. Targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci USA 1998; 95:13612–13617.[Abstract/Free Full Text]
  8. Linder CC, Heckert LL, Goetz TL, Griswold MD. Follicle-stimulating hormone receptor gene promoter activity. Endocrine 1994; 2:957–966.
  9. Yarney TA, Sairam MR, Khan H, Ravindranath N, Payne S, Seidah NG. Molecular cloning and expression of the ovine testicular follicle-stimulating hormone receptor. Mol Cell Endocrinol 1993; 93:219–226.[CrossRef][Medline]
  10. Findlay JK, Drummond AE. Regulation of the FSH receptor in the Ovary. Trends Endocrinol Metab 1999; 10:183–188.[CrossRef][Medline]
  11. Gromoll J, Dankbar B, Gudermann T. Characterization of the 5' flanking region of the human follicle-stimulating hormone receptor gene. Mol Cell Endocrinol 1994; 102:93–102.[CrossRef][Medline]
  12. Heckert LL, Daley IJ, Griswold MD. Structural organization of the follicle-stimulating hormone receptor gene. Mol Endocrinol 1992; 6:70–80.[Abstract]
  13. Sairam MR, Subbarayan VSR. Characterization of the 5' flanking region and potential control elements of the ovine follitropin receptor gene. Mol Reprod Dev 1997; 48:480–487.[CrossRef][Medline]
  14. Huhtaniemi I, Eskola V, Pakarinen P, Matikainen T, Sprengel R. The murine luteinizing hormone and follicle-stimulating hormone receptor genes: transcription initiation sites, putative promoter sequences and promoter activity. Mol Cell Endocrinol 1992; 88:55–66.[CrossRef][Medline]
  15. Rassoulzadegan M, Paquis-Flucklinger V, Bertino B, Sage J, Jasin M, Miyagawa K, Van Heyningen V, Besmer P, Cuzin F. Transmeiotic differentiation of male germ cells in culture. Cell 1993; 75:997–1006.[CrossRef][Medline]
  16. Chedrese PJ, Rodway MR, Swan CL, Gillio-Meina C. Establishment of a stable steroidogenic porcine granulosa cell line. J Mol Endocrinol 1998; 20:287–292.[Abstract]
  17. Xing W, Archer TK. Upstream stimulatory factors mediate estrogen receptor activation of the cathepsin D promoter. Mol Endocrinol 1998; 12:1310–1320.[Abstract/Free Full Text]
  18. Mancini DN, Rodenhiser DI, Ainsworth PJ, O'Malley FP, Singh SM, Xing W, Archer TK. CpG methylation within the 5' regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene 1998; 16:1161–1169.[CrossRef][Medline]
  19. Pognonec P, Roeder RG. Recombinant 43-kDa USF binds to DNA and activates transcription in a manner indistinguishable from that of natural 43/44-kDa USF. Mol Cell Biol 1991; 11:5125–5136.[Abstract/Free Full Text]
  20. Singh H, Clerc RG, LeBowitz JH. Molecular cloning of sequence-specific DNA binding proteins using recognition site probes. Biotechniques 1989; 7:252–261.[Medline]
  21. Augereau P, Miralles F, Cavaillès V, Gaudelet C, Parker M, Rochefort H. Characterization of the proximal estrogen-responsive element of human cathepsin D gene. Mol Endocrinol 1994; 8:693–703.[Abstract]
  22. Heckert LL, Griswold MD. Expression of the FSH receptor in the testis. Recent Prog Horm Res 1993; 48:61–77.
  23. Heckert LL, Griswold MD. Expression of follicle-stimulating hormone receptor mRNA in rat testes and Sertoli cells. Mol Endocrinol 1991; 5:670–677.[Abstract]
  24. Richards JS, Heldin L. Molecular aspects of hormone action in ovarian follicular development, ovulation, and luteinization. Annu Rev Physiol 1988; 50:441–463.[CrossRef][Medline]
  25. Sites CK, Patterson K, Jamison CS, Friezner Degen SJ, La Barbera AR. Follicle-stimulating hormone (FSH) increases FSH receptor messenger ribonucleic acid while decreasing FSH binding in cultured porcine granulosa cells. Endocrinology 1994; 134:411–417.[Abstract]
  26. Tilly JL, LaPolt PS, Hsueh AJ. Hormonal regulation of follicle-stimulating hormone receptor messenger ribonucleic acid levels in cultured rat granulosa cells. Endocrinology 1992; 130:1296–1302.[Abstract]
  27. Dunkel L, Tilly JL, Shikone T, Nishimori K, Hsueh AJW. Follicle-stimulating hormone receptor expression in the rat ovary: increases during prepubertal development and regulation by opposing actions of transforming growth factors ß and {alpha}. Biol Reprod 1994; 50:940–948.[Abstract]
  28. Nakamura K, Minegishi T, Takakura Y, Miyamoto K, Hasegawa Y, Ibuki Y, Igarashi M. Hormonal regulation of gonadotropin receptor mRNA in rat ovary during follicular growth and luteinization. Mol Cell Endocrinol 1991; 82:259–263.[CrossRef][Medline]
  29. Nakamura M, Minegishi T, Hasegawa Y, Nakamura K, Igarashi S, Ito I, Shinozaki H, Miyamoto K, Eto Y, Ibuki Y. Effect of activin A on follicle-stimulating hormone (FSH) receptor messenger ribonucleic acid levels and FSH receptor expression in cultured rat granulosa cells. Endocrinology 1993; 133:538–544.[Abstract]
  30. Minegishi T, Hirakawa T, Kishi H, Abe K, Abe Y, Mizutani T. A role of insulin-like growth factor I for follicle-stimulating hormone receptor expression in rat granulosa cells. Biol Reprod 2000; 62:325–333.[Abstract/Free Full Text]
  31. Goetz TL, Lloyd LT, Griswold MD. Role of E box and initiator region in the expression of the rat follicle-stimulating hormone receptor. J Biol Chem 1996; 271:33317–33324.[Abstract/Free Full Text]
  32. Heckert LL, Daggett MAF, Chen J. Multiple promoter elements contribute to activity of the follicle-stimulating hormone receptor (FSHR) gene in testicular Sertoli cells. Mol Endocrinol 1998; 12:1499–1512.[Abstract/Free Full Text]
  33. Rodway MR, Swan CL, Crellin NK, Gillio-Meina C, Chedrese PJ. Steroid regulation of progesterone synthesis in a stable porcine granulosa cell line: a role for progestins. J Steroid Biochem Mol Biol 1999; 68:173–180.[CrossRef][Medline]
  34. Rodway MR, Swan CL, Gillio-Meina C, Crellin NK, Flood PF, Chedrese PJ. Regulation of steroidogenesis in jc-410, a stable cell line of porcine granulosa origin. Mol Cell Endocrinol 1999; 148:87–94.[CrossRef][Medline]
  35. Bourdon V, Lablack A, Abbe P, Segretain D, Pointis G. Characterization of a clonal Sertoli cell line using adult PyLT transgenic mice. Biol Reprod 1998; 58:591–599.[Abstract/Free Full Text]
  36. Biesiada E, Hamamori Y, Kedes L, Sartorelli V. Myogenic basic helix-loop-helix proteins and Sp1 interact as components of a multiprotein transcriptional complex required for activity of the human cardiac {alpha}-actin promoter. Mol Cell Biol 1999; 19:2577–2584.[Abstract/Free Full Text]
  37. Hamamori Y, Wu HY, Sartorelli V, Kedes L. The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, twist. Mol Cell Biol 1997; 17:6563–6573.[Abstract]
  38. Moriuchi M, Moriuchi H, Margolis DM, Fauci AS. USF/c-myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry. J Immunol 1999; 162:5986–5992.[Abstract/Free Full Text]
  39. Lee TC, Ziff EB. Mxil is a repressor of the c-myc promoter and reverses activation by USF. J Biol Chem 1999; 274:595–606.[Abstract/Free Full Text]
  40. Adams CC, Workman JL. Binding of disparate transcriptional activators to nucleosomal DNA is inherently cooperative. Mol Cell Biol 1995; 15:1405–1421.[Abstract]
  41. Qyang Y, Luo X, Lu T, Ismail PM, Krylov D, Vinson C, Sawadogo M. Cell-type-dependent activity of the ubiquitous transcription factor USF in cellular proliferation and transcriptional activation. Mol Cell Biol 1999; 19:1508–1517.[Abstract/Free Full Text]
  42. Meisterernst M, Horikoshi M, Roeder RG. Recombinant yeast TFIID, a general transcription factor, mediates activation by the gene-specific factor USF in a chromatin assembly assay. Proc Natl Acad Sci USA 1990; 87:9153–9157.[Abstract/Free Full Text]
  43. Roy AL, Meisterernst M, Pognonec P, Roeder RG. Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF. Nature 1991; 354:245–248.[CrossRef][Medline]
  44. Roy AL, Du H, Gregor PD, Novina CD, Marinez E, Roeder RG. Cloning of an Inr-and E-box-binding protein, TFII-I, that interacts physically and functionally with USF-1. EMBO J 1997; 16:7091–7104.[CrossRef][Medline]



This article has been cited by other articles:


Home page
EndocrinologyHome page
B. P. Hermann, K. Hornbaker, D. A. Rice, M. Sawadogo, and L. L. Heckert
In Vivo Regulation of Follicle-Stimulating Hormone Receptor by the Transcription Factors Upstream Stimulatory Factor 1 and Upstream Stimulatory Factor 2 Is Cell Specific
Endocrinology, October 1, 2008; 149(10): 5297 - 5306.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. Selva, K. N. Hogeveen, and G. L. Hammond
Repression of the Human Sex Hormone-binding Globulin Gene in Sertoli Cells by Upstream Stimulatory Transcription Factors
J. Biol. Chem., February 11, 2005; 280(6): 4462 - 4468.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
W. Xing and M. R. Sairam
Retinoic Acid Mediates Transcriptional Repression of Ovine Follicle-Stimulating Hormone Receptor Gene via a Pleiotropic Nuclear Receptor Response Element
Biol Reprod, July 1, 2002; 67(1): 204 - 211.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
W. Xing, N. Danilovich, and M. R. Sairam
Orphan Receptor Chicken Ovalbumin Upstream Promoter Transcription Factors Inhibit Steroid Factor-1, Upstream Stimulatory Factor, and Activator Protein-1 Activation of Ovine Follicle-Stimulating Hormone Receptor Expression via Composite cis-Elements
Biol Reprod, June 1, 2002; 66(6): 1656 - 1666.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Chaudhary and M. K. Skinner
Identification of a Novel Gene Product, Sertoli Cell Gene with a Zinc Finger Domain, That Is Important for FSH Activation of Testicular Sertoli Cells
Endocrinology, February 1, 2002; 143(2): 426 - 435.
[Abstract] [Full Text] [PDF]


Home page
Recent Prog Horm ResHome page
L. L. Heckert and M. D. Griswold
The Expression of the Follicle-stimulating Hormone Receptor in Spermatogenesis
Recent Prog. Horm. Res., January 1, 2002; 57(1): 129 - 148.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
W. Xing and M. R. Sairam
Role of CACC-Box in the Regulation of Ovine Follicle-Stimulating Hormone Receptor Expression
Biol Reprod, October 1, 2001; 65(4): 1142 - 1149.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xing, W.
Right arrow Articles by Ram Sairam, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xing, W.
Right arrow Articles by Ram Sairam, M.
Agricola
Right arrow Articles by Xing, W.
Right arrow Articles by Ram Sairam, M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS